We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock

Delisted

FRTX was delisted on the 18th of December, 2023.

26 hedge funds and large institutions have $6.31M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% less funds holding

Funds holding: 3626 (-10)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

31% less capital invested

Capital invested by funds: $9.18M → $6.31M (-$2.87M)

75% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 12

Holders
26
Holders Change
-10
Holders Change %
-27.78%
% of All Funds
0.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
5
Reduced
7
Closed
12
Calls
Puts
Net Calls
Net Calls Change

FRTX Hedge Fund Activity: Q4 2016 in Review

26 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q4 2016, worth a combined $6.31M — down 31% from $9.18M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of FRTX and 3 opened new positions — a net loss of 9 holders — while 7 trimmed existing stakes and 5 added.

The largest buyer was Renaissance Technologies, adding an estimated $91.8K. The largest seller was ClariVest Asset Management, exiting entirely with an estimated $215K sold.

  • 26 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q4 2016, down from 36 in Q3 2016.
  • Funds reported $6.31M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q4 2016, down 31% quarter-over-quarter.
  • 3 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q4 2016 and 12 closed out, a net change of -9 holders.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q4 2016 was Renaissance Technologies, an estimated $91.8K added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q4 2016 was ClariVest Asset Management, an estimated $215K sold.

Based on aggregated 13F filings for Q4 2016.